Testing effectiveness (Phase 2)Study completedNCT01262469
What this trial is testing
Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.
Who this might be right for
Metastatic Breast Cancer70 Years Old Patients and OverAfter One Line of Chemotherapy With Trastuzumab
UNICANCER 4